Euthymics Bioscience (DOVP) Inactive 10-Q2007 Q1 Quarterly report

Filed: 15 May 07, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: analyzed, banker, beneficial, book, check, complex, consummated, consummating, consummation, delivered, diversity, equivalent, escalating, Europe, exceed, extinguishment, fact, filer, freely, hedge, insignificant, Japan, kaltnecker, landlord, larger, mandatorily, Mandatory, mitigate, parent, plc, reclassified, repaid, resubmit, return, revalued, sheet, shell, shorter, sooner, sublicensee, sustained, tradeable, Troubled, Washington, william, women, XTL

Removed: account, accounted, acquirer, add, analgesic, annually, APB, assumed, assumption, aware, broadest, code, collect, commensurate, concurrence, consecutive, constitute, counsel, critical, dated, decision, declared, discontinued, disorder, divest, dividend, elevation, ending, enterprise, enzyme, establishment, exceeded, excluding, execute, exercised, expanded, extended, flexibility, flow, forma, function, GAD, Horton, Hudson, implementation, implemented, implied, improved, inclusion, initially, involve, involving, joined, line, liver, mailing, meaningful, modified, neuronal, nominal, noted, occupancy, operational, partnering, path, pattern, paying, percent, performing, Pfizer, pivotal, plain, postponed, premium, presently, president, pricing, pro, processing, promissory, prospective, put, reassume, redeem, registration, relocation, reorganize, representative, Reserve, responsibility, responsible, restate, restated, retained, retaining, reuptake, reviewed, Robert, SAB, salary, sell, separation, shareholder, shelf, simplified, standard, subjective, subsequently, supplied, suspended, taxable, test, timeline, treasury, triple, Unearned, unvested, vanilla, vested, vesting, vice, view, weighted

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

DOVP similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

Certification by the Chief Executive Officer and Principal Financial Officer Pursuant to 18 U. S. C. Section 1350, as

Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U. S. C. Section 1350, I, Barbara Duncan, hereby certify that, to the best of my knowledge, the Quarterly Report on Form 10-Q of DOV Pharmaceutical, Inc. for the quarter ended March 31, 2007 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of DOV Pharmaceutical, Inc.

A signed original of this written statement required by Section 906 has been provided to DOV and will be retained by DOV and furnished to the Securities and Exchange Commission or its staff upon request.


/s/ Barbara Duncan
Barbara Duncan Chief Executive Officer and Principal Financial Officer May 15, 2007

This certification accompanies this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act, except to the extent that the Company specifically incorporates it by reference.